XML 44 R5.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands
6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Cash flows from operating activities    
Net income $ 26,571 $ 15,903
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Loss on sale of assets 48 404
Depreciation and amortization 10,055 12,501
Impairment loss on assets held for sale 1,094 17,566
Deferred income taxes (1,026) (5,396)
Noncash compensation related to stock plans 2,377 768
Loss in equity method investment 82 275
Excess tax benefit of options exercised 4 (10)
Provision for (recovery of) doubtful accounts 179 (189)
Provision for excess and obsolete inventory   4,932
Accrued interest earned from related party (58)  
Changes in operating assets and liabilities:    
Trade accounts receivable (48,234) (41,951)
Inventories (12,404) (15,703)
Trade accounts payable (2,386) 1,854
Income taxes payable 7,890 6,883
Accrued profit sharing trust contributions (2,611) (3,459)
Accrued cash profit sharing and commissions 10,160 6,966
Other current assets 410 (540)
Accrued liabilities 3,215 4,373
Long-term liabilities (42) 190
Accrued workers' compensation 979 34
Other noncurrent assets 352 158
Net cash provided by (used in) operating activities (3,345) 5,559
Cash flows from investing activities    
Capital expenditures (14,095) (21,628)
Proceeds from sale of capital assets 3,156 60
Loans made to related parties   (1,798)
Loans repaid by related parties 26 50
Net cash used in investing activities (10,913) (23,316)
Cash flows from financing activities    
Repurchase of common stock (50,075)  
Issuance of common stock 154 955
Excess tax benefit of options exercised (4) 10
Dividends paid (11,274) (9,879)
Net cash used in financing activities (61,199) (8,914)
Effect of exchange rate changes on cash and cash equivalents 2,421 (3,947)
Net decrease in cash and cash equivalents (73,036) (30,618)
Cash and cash equivalents at beginning of period 335,049 250,381
Cash and cash equivalents at end of period 262,013 219,763
Noncash activity during the period    
Noncash capital expenditures 1,587 226
Dividends declared but not paid 6,263 4,978
Issuance of Company's common stock for compensation $ 204 $ 277